X
Century gets $250m to develop next-gen ‘off the shelf’ cancer cell therapies
https://pharmaphorum.com/news/century-gets-250m-to-develop-next-gen-off-the-shelf-cancer-cell-therapies/
Allogene
Allogene raises another $120m to develop ‘off-the-shelf’ CAR-Ts
Startup biotech already raised $300m earlier this year
Ex-Kite chiefs’ biotech to research ‘off-the-shelf’ CAR-Ts with Cellectis
Belldegrun and Chang’s Allogene to take over from Pfizer in R&D deal